Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...
The Indian data centre industry has urged MeitY for clear timelines on approvals and easier right-of-way access to speed up new projects. Industry players also seek incentives and operational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback